{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6usaAKDA","lastupdate":"2023-01-19T00:00:00.000Z","update_date":"2023-01-19T00:00:00.000Z","lastModified":"Aug 14, 2025","active":1,"confidence_score":100,"confidence_score_reason":"markets","urlname":"vibrant-gastro","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$Ws9DkX6moocK2sLAcLxZChVZjPFKLPUOnlCJInERg4Bu2511jLFzfi","name":"Vibrant Gastro","oneliner":"Drug-free Treatment of Chronic Idiopathic Constipation","registrar":"514030659","website":"https://vibrantgastro.com","careerspage":"https://www.vibrantgastro.com","founded_month":9,"founded_year":2007,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/vibrantgastro","youtube":"https://www.youtube.com/@vibrantgastro458","facebook":"https://www.facebook.com/vibrantgastro","linkedin":"https://www.linkedin.com/company/71487937","instagram":""},"social":["https://www.youtube.com/@vibrantgastro458","https://www.facebook.com/vibrantgastro","https://www.linkedin.com/company/71487937","https://twitter.com/vibrantgastro"],"flattenedsociallinks":"https://www.youtube.com/@vibrantgastro458|https://www.facebook.com/vibrantgastro|https://www.linkedin.com/company/71487937|https://twitter.com/vibrantgastro","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":21,"patent":1,"raised":7500000,"stage":"E","public_stage":"E","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Vibrant Capsule","Vibrant Gastro"],"about":"Vibrant Gastro is the developer of the Synchronized Activation Method, a groundbreaking drug-free technology system that uses gentle vibrations to stimulate the colon mechanically. The preprogrammed timing of the mechanical stimulation is designed to improve natural colonic motility by leveraging the colon’s biological clock.\n\nThe company’s technology system allows for future development of data-driven personalized treatments and additional indications leveraging the gut-brain connection via the enteric nervous system pathway.\n\nVibrant Gastro’s first indication is for treating adults with chronic idiopathic constipation who have not experienced relief of their symptoms after using laxative therapies at the recommended dosage for at least one month.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+9724663322","country":null,"address":{"israeli":[{"id":"550e4a43-00bf-4dfd-a282-46f2ea9e5c8e","city":"Yokne'am Illit","type":null,"address":"Yokne'am Illit, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"North District","news":[{"id":"o61NFTPhNfxYixujBxAyl2bjpXc49MInYBRevbguNWtyeS9SOR013d","date":"Aug 31, 2022","link":"https://www.medicaldesignandoutsourcing.com/vibrant-gastro-drug-free-chronic-constipation-treatment-fda/","source":"www.medicaldesignandoutsourcing.com","visible":1,"analysis":{"tags":"medical device","company":"Vibrant Gastro","layoffs":null,"summary":"Vibrant Gastro has received FDA marketing authorization for its vibrating, drug-free capsule for treating chronic constipation. The capsule, which is activated in an accompanying pod, works by mechanically stimulating the colon and resynchronizing the biological clock to improve bowel movements. The device will be available in select U.S. states early next year and will expand nationally throughout 2023. Clinical trials showed that patients using the Vibrant capsule had at least one additional bowel movement per week compared to the control group. Vibrant Gastro aims to provide a drug-free treatment option for chronic constipation patients and plans to seek an expansion of indications in the future.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Vibrant capsule","chronic constipation","FDA authorization","drug-free treatment","biological clock"],"date_of_event":"August 26, 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"H50D05cn89euF1pfxaIN0YSwJ7jpzezN6UkL9Z4STl4Tn95dthRMib","news_summary":"How Vibrant Gastro's vibrating pill treats chronic constipation without drugs","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"mvFOFCd5m8W6JjQ7Jd5SJ04lGCvth5siQEWgVXXBIOZJQlQ96SuP9O","date":"May 22, 2022","link":"https://www.prnewswire.com/news-releases/vibrants-novel-drug-free-treatment-demonstrates-positive-efficacy-and-safety-results-in-adults-with-chronic-idiopathic-constipation-in-pivotal-phase-3-study-301552332.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical technology","company":"Vibrant Gastro","layoffs":null,"summary":"Vibrant Gastro presented positive Phase 3 data for its drug-free treatment for chronic idiopathic constipation (CIC) at the 2022 Digestive Disease Week Conference. The data showed significant improvement in bowel movement frequency, constipation symptoms, and quality of life in adults with CIC. The company has submitted the Phase 3 data to the U.S. Food and Drug Administration for clearance. The trial involved 312 CIC patients at over 90 clinical centers across the U.S. Vibrants drug-free mechanism of action is based on resynchronizing the biological clock through mechanical stimulation of the colon. The company aims to provide a cost-effective solution for chronic constipation and expand treatment options for healthcare providers.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Phase 3 data","chronic idiopathic constipation","Vibrant System","treatment","clinical trial"],"date_of_event":"2022-05-22","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"G1zNoTC70obPE4M4UYXKwhgTLJAGQOnxsiusTkCYPFDxWAKpVx5JOc","news_summary":"Vibrant's Novel Drug-Free Treatment Demonstrates Positive Efficacy and Safety Results in Adults with Chronic Idiopathic Constipation in Pivotal Phase 3 Study","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"79db4f15-8055-4efa-8b86-d794cdb5ed0c","date":"Mar 26, 2021","link":"https://www.prnewswire.com/il/news-releases/constipation-treatment-vibrant-raises-7-5-million-led-by-unorthodox-ventures-301256492.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"funding","company":"Vibrant","layoffs":null,"summary":"Vibrant, a developer of gastrointestinal treatments, has announced the first closing of a $7.5 million Series E funding round led by Unorthodox Ventures. Vibrant has developed a non-drug treatment for chronic constipation that uses a vibrating capsule to stimulate bowel movements. The treatment is currently in its third round of trials with the FDA. The funding will support Vibrants expected rollout and the company is actively engaging with physicians and insurers. Unorthodox Ventures Founding Contrarian, Carey Smith, will join Vibrants Board of Directors. Vibrant is aiming to provide a real solution for the millions of Americans suffering from chronic constipation.","partners":null,"customers":null,"investors":"Unorthodox Ventures","confidence":9,"key_topics":["Series E funding","non-drug treatment","chronic constipation","vibrating capsule","Unorthodox Ventures"],"date_of_event":"March 26, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$7.5 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"TQ0c3kJaisNvoIHCiqPp6ZSJ12o5zbAfCR3XZaoTmNv3Npkh3H88Qm","news_summary":"Constipation treatment Vibrant raises $7.5 million led by Unorthodox Ventures","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"58fb6764-6d37-4b1b-aca1-d6f8c04cb058","date":"Apr 4, 2019","link":"https://www.medgadget.com/2019/04/swallowable-vibrating-pill-shakes-faecis-to-relieve-constipation.html","source":"www.medgadget.com","visible":1,"analysis":{"tags":"medical gadgetry","company":"Vibrant","layoffs":null,"summary":"Israeli company Vibrant has developed a drug-free pill called the Vibrant capsule, which is swallowed like a typical pill and is programmed to vibrate in order to stimulate bowel movements. The capsule has been evaluated for effectiveness on patients with Chronic Idiopathic Constipation and Irritable Bowel Syndrome with Constipation, showing positive results. The capsule is able to shake up the walls of the large intestine, freeing up tough buildup. The article highlights the benefits of the Vibrant capsule as a medication-free solution for constipation.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Constipation","Vibrant capsule","drug-free pill","large intestine","medical gadgetry"],"date_of_event":"April 4th, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"igktI5a0L34by5NsZb6oLjaUmpWmc89isezVvMpUWBVXQ0pBqcWwG4","news_summary":"Swallowable Vibrating Pill Shakes Faecis to Relieve Constipation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"257b4e9c-81a1-491e-ad93-c9eef8f5fb8f","date":"Jan 2, 2019","link":"https://bottomlineinc.com/health/digestive/drug-free-constipation-cure-vibrating-pill","source":"bottomlineinc.com","visible":1,"analysis":{"tags":"constipation relief","company":"Vibrant","layoffs":null,"summary":"Israeli company Vibrant has developed a vibrating capsule to provide relief for chronic constipation. The capsule, which is swallowed and programmed to vibrate in the large intestine, stimulates natural peristaltic activity and induces bowel movements. In early clinical trials, the Vibrant capsule doubled the number of bowel movements and achieved effective relief in 90% of patients within eight weeks. The capsule is about the size of a fish oil pill and has no side effects. Vibrant plans to conduct larger trials in 10 to 12 research centers starting in early 2019, with the goal of obtaining FDA approval and making the capsule available in about three years.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["chronic constipation","vibrating capsule","clinical trials","FDA approval","long-term studies"],"date_of_event":"early 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"EdWgIQzHUaAUQRhG0AVF9LiDDn7c16WOJRwaOscDRkRQROYRQqdCRF","news_summary":"Drug-Free Constipation Cure: A Vibrating Pill  Bottom Line Inc","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4118ea57-3fc4-43f8-ab36-a1111ba7d23f","date":"Oct 9, 2018","link":"https://www.dailymail.co.uk/health/article-6256171/Swallowing-vibrating-capsule-relieve-constipation-stimulating-stomach-contractions.html","source":"www.dailymail.co.uk","visible":1,"analysis":{"tags":"medical technology","company":"Vibrant","layoffs":null,"summary":"A vibrating capsule developed by Vibrant, an Israeli company, has shown promise in relieving chronic constipation. The capsule, programmed to vibrate in the large intestine, stimulates stomach contractions and helps move digestion along. In a study with 245 participants, those who took the vibrating capsules had twice as many bowel movements per week compared to those taking a placebo. If larger studies confirm its safety and effectiveness, the medication could be available in three years. Constipation affects millions of people in the US and UK. Vibrant plans to conduct a larger study to further investigate the capsules ability to relieve constipation.","partners":["Augusta University"],"customers":null,"investors":null,"confidence":8,"key_topics":["vibrating capsule","chronic constipation","bowel movements","medication","research"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pZgnTHQNEUXD9dz57Av399Vkq6CVxsSS0tMkFOEzizEM4VEjgaPpmE","news_summary":"Swallowing a vibrating capsule could relieve constipation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"81f24081-4a86-44dc-aa09-a64c8310247f","date":"Oct 4, 2017","link":"https://www.prnewswire.com/news-releases/vibrant-successfully-completes-two-clinical-studies-showcasing-the-efficacy-of-worlds-first-vibrating-capsule-to-treat-chronic-constipation-649401903.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"innovation, constipation treatment","company":"Vibrant Ltd.","layoffs":null,"summary":"Vibrant Ltd. has successfully completed clinical studies for its intraluminal vibrating capsule for treating chronic constipation. The capsule stimulates the colon with mechanical vibrations, providing a non-chemical treatment option. The results of the studies will be presented at WCOG 2017. Vibrant is currently recruiting for additional clinical studies in the US and sees potential in treating other constipation disorders.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["clinical studies","intraluminal vibrating capsule","chronic constipation","treatment efficacy","potential for other constipation disorders"],"date_of_event":"October 4, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CUjL8sDhxa1T9k4b9CImgm56Eci4eSevQU8Wwf7cgu9vd2NdEwbouQ","news_summary":"Vibrant Successfully Completes Two Clinical Studies Showcasing the Efficacy of World's First Vibrating Capsule to Treat Chronic Constipation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ec909240-8758-4977-a8d7-0929be6178d3","date":"Jan 31, 2017","link":"http://health.wusf.usf.edu/post/study-starts-vibrating-pill-treat-constipation#stream/0","source":"health.wusf.usf.edu","visible":1,"analysis":{"tags":"medical device","company":"Vibrant Ltd.","layoffs":null,"summary":"Israeli medical device company Vibrant Ltd. has developed a vibrating capsule for the treatment of chronic constipation. Oviedo Medical Research in the U.S. is one of six sites enrolling patients for a clinical study on the effectiveness of the vibrating capsule. The company plans to submit the capsule for FDA approval and estimates it will be sold at a similar price range as prescription medication for chronic constipation. Patients enrolled in the study will receive the capsules for free and will be reimbursed for their time and travel. The vibrating capsule is expected to be a cost-effective and side effect-free treatment for chronic constipation.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["vibrating capsule","chronic constipation","FDA approval","clinical study","medical device"],"date_of_event":"June 30, 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"4LqQJ5CJfu3j7N0bAkjDCOglYwrFKTPwAB2igOmolL25Od1nzsznyS","news_summary":"Study Starts For Vibrating Pill To Treat Constipation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"23db5b6b-773d-4b5f-9033-e5c435df32bd","date":"Feb 2, 2015","link":"http://www.meddeviceonline.com/doc/vibrating-capsule-may-relieve-chronic-constipation-0001","source":"www.meddeviceonline.com","visible":1,"analysis":{"tags":"medical technology","company":"Vibrant Ltd.","layoffs":null,"summary":"Vibrant Ltd., a company specializing in medical technology, has developed a vibrating capsule that can be used to treat chronic constipation. The capsule stimulates the bowel by vibrating inside the large intestine, providing relief for patients who do not respond well to laxatives. The company is conducting a nationwide clinical trial to determine the effectiveness of the capsule in alleviating constipation. The trial is a randomized, double-blind investigation that will last for 12 weeks. Patients will be divided into two groups, one of which will receive a placebo. The capsule has the potential to revolutionize constipation treatment and provide alternative options for patients.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["vibrating capsule","constipation treatment","clinical trial","bowel stimulation","gastrointestinal tract"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"0HqSuhMdzidgZpgyMsegXf0ZnKrb3IbofGIwuKtkebUFChwFdSPWGy","news_summary":"Vibrating Capsule May Relieve Chronic Constipation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"018b7865-86e6-449e-945b-269de733e2a4","date":"Jan 29, 2015","link":"http://www.healio.com/gastroenterology/motility/news/online/%7B5a3a4eee-6baa-46a1-a08b-6fa5e40b8b0a%7D/clinical-trial-for-vibrating-capsule-for-chronic-constipation-underway","source":"www.healio.com","visible":1,"analysis":{"tags":"clinical trial","company":"Temple University Hospital","layoffs":null,"summary":"Temple University Hospital is conducting a clinical trial to test a new vibrating capsule for patients with chronic constipation. The trial aims to determine the efficacy of the capsule in alleviating constipation. Participants will be randomly assigned to receive the capsule or a placebo and will record their symptoms in a diary. The device is programmed to vibrate after being swallowed, stimulating intestinal contractions. The trial is sponsored by Vibrant Ltd.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["clinical trial","vibrating capsule","chronic constipation","efficacy","randomized"],"date_of_event":"January 29, 2015","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"F5uHx3iuZsL7mq4hE9Fpaau7ij6ZCCWKFCinYpsuw8Q99Otewu1Lek","news_summary":"Clinical trial for vibrating capsule for chronic constipation underway","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"62b3672a-8155-42e2-b13e-2ab68a4e6a8b","date":"Jan 28, 2015","link":"http://medcitynews.com/2015/01/israeli-startup-vibrating-anti-constipation-pills-conducting-clinical-trials-stateside/","source":"medcitynews.com","visible":1,"analysis":{"tags":"medical technology","company":"Vibrant Ltd.","layoffs":null,"summary":"Israeli startup Vibrant Ltd. is recruiting for U.S. clinical trials for its vibrating pill designed to alleviate chronic constipation. The pill, controlled by external algorithms, induces natural peristaltic activity in the large intestine, leading to bowel movements. Vibrant is actively seeking partnerships. The companys constipation trial is screening patients at various U.S. centers, aiming to study the effectiveness of the pill for patients with fewer than three bowel movements per week. The goal is to achieve one additional spontaneous bowel movement per week over eight months. Chronic constipation is a common problem in the U.S. that often doesnt respond well to current treatments. Temple University is one of the participating institutions in the trial.","partners":null,"customers":null,"investors":"private investors, founders","confidence":8,"key_topics":["vibrating pill","U.S. clinical trials","constipation","smart pills","ethical concerns"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"XyOCyNvS0j0nAtx9twiOLuieQOwcPem3MIajvVyvuSzMJfpyDBCaks","news_summary":"That Israeli startup with the vibrating anti-constipation pills is conducting clinical trials stateside","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"82a6c996-8726-43c0-81e8-944085a67077","date":"May 3, 2014","link":"https://www.nbcnews.com/health/health-news/laxatives-fail-you-try-vibrating-pill-n93856","source":"www.nbcnews.com","visible":1,"analysis":{"tags":"medical technology","company":"Vibrant Ltd","layoffs":null,"summary":"Israeli researchers, with U.S. federal funding, have been testing an experimental vibrating capsule developed by Vibrant Ltd as a drug-free alternative for people with chronic constipation or irritable bowel syndrome. The capsule nearly doubled the number of bowel movements in volunteers, providing a potential solution for those who are unhappy with the results they get from laxatives. The capsule is still in the experimental stage and not yet approved for use.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["vibrating capsule","chronic constipation","irritable bowel syndrome","bowel movements","laxatives"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"JvgxBEPzrmriEhmEfCQdkLFoWhfeRkOMDysbzvuRvYMop4xdCFYSA2","news_summary":"Laxatives Fail You? Try a Vibrating Pill","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":12,"techcommunityinvolvement":null,"mediagallery":[{"id":"GTwpfUGEatF4peFRyOtR5dyiutC6SZMFknDaUOyhuy0ZFoWL82xJes","timestamp":"2023-01-19 18:25:34.000000","resources_type":2,"resources_title":"","resources_file_name":"SRkH-etM9RE","alt":"","imageurl":"https://img.youtube.com/vi/SRkH-etM9RE/0.jpg","url":"http://youtu.be/SRkH-etM9RE"}],"tags":["gastroenterology","medical-products","chronic-patients","digital-healthcare","mobile-applications","remote-monitoring","digital-therapeutics","insurance-companies","doctors","healthcare-providers"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81bgJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2OAKDA"],"technologysuccessstory":[{"date":"2007-09-01","name":"Chemical-free vibrating capsule for constipation","tags":["medical-products","gastroenterology"],"category":"Medical Devices","tto_logo":"/image_cloud/mor-research-applications_tto_logo_ebbdad70-6016-11e8-a05b-41fdcbb0dda6","university_logo":"/image_cloud/mor-research-applications_institution_logo_ebbdad70-6016-11e8-a05b-41fdcbb0dda6"}],"usecases":[],"businessmodels":["B2B","B2C"],"productstage":"Released","products":[],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":4,"lastfunding":"$7.5M","totalrounds":3,"fundingstage":"E","totalfunding":"$7.5M","publicinvestors":4,"lastpublicfunding":7500000,"totalpublicrounds":3,"totalpublicfunding":7500000},"team":[{"name":"Asaf Bar","email":"asaf.b@vibrantgastro.com","phone":"","gender":"Male","userid":"yhZoqeYlUFsppfOZVFbSu0PZ4pR75nFlUCP3HyPsZZmXBXj18zJZyx","bounced":false,"claimed":1,"founder":0,"urlname":"asaf-bar-7","visible":1,"memberid":"eTn4SFv7OOfIX58q7kRLWbx6aVQD3Gn26FPbXxCwK7QHOT6ep172EA","position":"CEO","last_name":"Bar","claimtoken":"JKFPpLNKRxQLxSB3lzMIOv79XAeRCkGeI71Ib4GfI0fY1Mf9nCfgce","first_name":"Asaf","picturekey":null,"claimeddate":"2024-09-24","linkedinurl":"https://www.linkedin.com/in/asafb/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-09-24 14:36:18.000000","initials":"AB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Lior Ben-Tsur","email":"Lior.b@vibrantgastro.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLG1i40IDA","bounced":false,"claimed":0,"founder":0,"urlname":"lior-ben-tsur","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAsYWd3woM","position":"Co-founder & Chief Clinical Consultant","last_name":"Ben-Tsur","claimtoken":"MZkwtDDhHeA3jjtbXIXr2eGYTKgTrHh3DhLfeVX860e497sBvumdmX","first_name":"Lior","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/lior-bentsur-24559ab0/","unsubscribed":false,"is_activeuser":0,"additionalemail":"bentsur.lior@gmail.com","claimedemaildate":"2023-01-19 18:33:30.000000","initials":"LB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Eli Gendler","email":"eli.g@vibrantgastro.com","phone":"0546661093","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNWdwtcJDA","bounced":false,"claimed":0,"founder":0,"urlname":"eli-gendler-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg1Z3WzggM","position":"CFO","last_name":"Gendler","claimtoken":"2LuiiocHrGHtGRPFEoLI9tngcy2ZKcmfCffe74awzgwwXrbX1HgT6v","first_name":"Eli","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/eligendler/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-01-19 18:34:11.000000","initials":"EG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Martha Bezalel","email":"martha.b@vibrantgastro.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoLbDgtIKDA","bounced":false,"claimed":0,"founder":0,"urlname":"martha-bezalel","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg1veLrAgM","position":"COO","last_name":"Bezalel","claimtoken":"l0lD25jC2Cd7JwjQEPGWTjMlIbTOJVOMPOT2QOW8ibKs0CHmGD97R4","first_name":"Martha","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/martha-bezalel-36298b81/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-01-19 18:34:08.000000","initials":"MB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shai Molnar","email":"shai.m@vibrantgastro.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4IfeyOILDA","bounced":false,"claimed":0,"founder":0,"urlname":"shai-molnar","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgh_yK1QgM","position":"VP R&D","last_name":"Molnar","claimtoken":"VKM88Ig60YhrXtxl19YTdIupdlQrnWG6O3IkFM7UMQlH19AnwDBUZ1","first_name":"Shai","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shai-molnar-782013120/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-01-19 18:34:34.000000","initials":"SM","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Uri Neria","email":"uri.ne@vibrantgastro.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4If-utwKDA","bounced":false,"claimed":1,"founder":0,"urlname":"uri-neria","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg-8OhwQkM","position":"Head of Product","last_name":"Neria","claimtoken":"9f49ab34c148cb1f4a895abeb230630d94c129e8bf5236bb25ec6b3d605bc6fe","first_name":"Uri","picturekey":null,"claimeddate":"2021-03-31","linkedinurl":"https://www.linkedin.com/in/uri-neria-4a7a0/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2021-03-31 12:35:07.000000","initials":"UN","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2019-10-27T00:00:00.000Z","crunchbaseid":"vibrant-ltd","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Yanina Wainscheinker","creator_email":"yanina.wain@gmail.com","createdate":"2015-02-09T00:00:00.000Z","biverification":"Jenny Sotnik-Talisman","sectorverification":"Sharon Shapira","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD7_f_MCgw","date":"Mar 2021","amount":"$7.5M","source":"https://finder.startupnationcentral.org/company_page/vibrant","eventtype":"FundingRoundEvent","investment":[{"name":"Unorthodox Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/unorthodox-ventures","logokey":"$YU0iKKGwpVQLLNVxZM3aVBsaxzFJpF7rRORojhMO5Jw14uViE0E4JI","tagline":null,"urlname":"/investor_page/unorthodox-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4LzZvtEIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"229c193a-87e0-4d61-8b31-bdda9e3da538","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YU0iKKGwpVQLLNVxZM3aVBsaxzFJpF7rRORojhMO5Jw14uViE0E4JI","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""},{"name":"Sequoia Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/sequoia-israel","logokey":"$X4XlkgDyQMSDU8pi8mipGGsgluWQCCZAaHNlpWtByvIgHPs5UXNb4w","tagline":null,"urlname":"/investor_page/sequoia-israel","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP74u9UKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"313253ba-ed4b-45b5-ab6a-639d5d1dcdfd","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$X4XlkgDyQMSDU8pi8mipGGsgluWQCCZAaHNlpWtByvIgHPs5UXNb4w","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"E Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":7500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"nBb2LYf8JIMTcIFPs8qG9G7PKuBRTLCSuRksbEv30xF1q4DbnkTFZz","date":"Apr 2019","amount":"Undisclosed","source":"pitchbook","eventtype":"FundingRoundEvent","investment":[{"name":"Tal Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/tal-capital","logokey":"$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","tagline":null,"urlname":"/investor_page/tal-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PGjr50KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"V6qcYTbLugxtSbD1uLAJdNuNLilxxjGPq3mKcqhbBfAVFFlSgO6011","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","leadcaption":"","followupcaption":""},{"name":"Gefen Capital","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/gefen-capital","logokey":"$ZI7b9eFCiOhZeoUvNSwZbsNUdJPyzReYxhUPIAVYoEcsiksRwxoXNw","tagline":null,"urlname":"/investor_page/gefen-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwIGUvYsKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"oqmSbgwftjzDqq7jmDHihjdzcx9LBgz2WGN39oSePXwBFxg7UgHpVg","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ZI7b9eFCiOhZeoUvNSwZbsNUdJPyzReYxhUPIAVYoEcsiksRwxoXNw","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"D Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC4jrHeCgw","date":"Jan 2014","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Sequoia Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/sequoia-israel","logokey":"$X4XlkgDyQMSDU8pi8mipGGsgluWQCCZAaHNlpWtByvIgHPs5UXNb4w","tagline":null,"urlname":"/investor_page/sequoia-israel","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP74u9UKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2f2c394e-352f-4af5-9257-5d9b82f4ae94","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$X4XlkgDyQMSDU8pi8mipGGsgluWQCCZAaHNlpWtByvIgHPs5UXNb4w","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"9/2007","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Vibrant Gastro","logourl":"https://storage.googleapis.com/clean-finder-353810/$Ws9DkX6moocK2sLAcLxZChVZjPFKLPUOnlCJInERg4Bu2511jLFzfi","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$Ws9DkX6moocK2sLAcLxZChVZjPFKLPUOnlCJInERg4Bu2511jLFzfi","seoabout":"Vibrant Gastro is the developer of the Synchronized Activation Method, a groundbreaking drug-free technology system that uses gentle vibrations to stimulat...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":6,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Digital Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81bgJDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":2,"name":"Vibration","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2OAKDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Digital Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81bgJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA>Vibration#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2OAKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Digital Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81bgJDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA|2:>TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA/Vibration#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2OAKDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Digital Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Digital Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"},{"title":"Patients","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]}]}],"coreTechnology":[{"title":"Sensing","key":"0-0","path":"TechnologyClassificationModel>Sensing","children":[{"title":"Vibration","key":"0-0-0","path":"TechnologyClassificationModel>Sensing>Vibration"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Digital Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81bgJDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":2,"name":"Vibration","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2OAKDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Digital Therapeutics"],"coreTechnology":["Sensing","Vibration"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers","Patients"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD7_f_MCgw","date":"Mar 2021","amount":"$7.5M","source":"https://finder.startupnationcentral.org/company_page/vibrant","eventtype":"FundingRoundEvent","investment":[{"name":"Unorthodox Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/unorthodox-ventures","logokey":"$YU0iKKGwpVQLLNVxZM3aVBsaxzFJpF7rRORojhMO5Jw14uViE0E4JI","tagline":null,"urlname":"/investor_page/unorthodox-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4LzZvtEIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"229c193a-87e0-4d61-8b31-bdda9e3da538","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YU0iKKGwpVQLLNVxZM3aVBsaxzFJpF7rRORojhMO5Jw14uViE0E4JI","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""},{"name":"Sequoia Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/sequoia-israel","logokey":"$X4XlkgDyQMSDU8pi8mipGGsgluWQCCZAaHNlpWtByvIgHPs5UXNb4w","tagline":null,"urlname":"/investor_page/sequoia-israel","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP74u9UKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"313253ba-ed4b-45b5-ab6a-639d5d1dcdfd","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$X4XlkgDyQMSDU8pi8mipGGsgluWQCCZAaHNlpWtByvIgHPs5UXNb4w","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"E Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":7500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"nBb2LYf8JIMTcIFPs8qG9G7PKuBRTLCSuRksbEv30xF1q4DbnkTFZz","date":"Apr 2019","amount":"Undisclosed","source":"pitchbook","eventtype":"FundingRoundEvent","investment":[{"name":"Tal Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/tal-capital","logokey":"$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","tagline":null,"urlname":"/investor_page/tal-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PGjr50KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"V6qcYTbLugxtSbD1uLAJdNuNLilxxjGPq3mKcqhbBfAVFFlSgO6011","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","leadcaption":"","followupcaption":""},{"name":"Gefen Capital","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/gefen-capital","logokey":"$ZI7b9eFCiOhZeoUvNSwZbsNUdJPyzReYxhUPIAVYoEcsiksRwxoXNw","tagline":null,"urlname":"/investor_page/gefen-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwIGUvYsKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"oqmSbgwftjzDqq7jmDHihjdzcx9LBgz2WGN39oSePXwBFxg7UgHpVg","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ZI7b9eFCiOhZeoUvNSwZbsNUdJPyzReYxhUPIAVYoEcsiksRwxoXNw","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"D Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC4jrHeCgw","date":"Jan 2014","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Sequoia Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/sequoia-israel","logokey":"$X4XlkgDyQMSDU8pi8mipGGsgluWQCCZAaHNlpWtByvIgHPs5UXNb4w","tagline":null,"urlname":"/investor_page/sequoia-israel","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP74u9UKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2f2c394e-352f-4af5-9257-5d9b82f4ae94","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$X4XlkgDyQMSDU8pi8mipGGsgluWQCCZAaHNlpWtByvIgHPs5UXNb4w","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}